Psychedelic-Assisted Psychotherapy for Complex Trauma: Core Principals and Clinical Applications for the Future of Trauma Treatment

Disclaimer: This Psychedelics Summit is provided for educational purposes only. Please note that the laws and regulations around the use of psychedelics differ between countries. Therefore, please ensure you abide by the laws, regulations and professional standards applicable to you.

Psychedelic-Assisted Psychotherapy (PAP) has been proven to treat even the most complex trauma faster, for longer, and without causing your clients more pain.

It's no wonder that your clients are trying to do PAP on their own or asking you about it. Now is the time to get the education to answer their questions like the experts.

Sit side-by-side with Linda Curran as she interviews an all-star cast of renowned experts who will show you exactly how PAP has turned the field of trauma treatment upside down. Plus, hear how they're integrating PAP and other altered-state healing practices into trusted modalities you're already using, like Internal Family Systems (IFS), Polyvagal Theory, Acceptance and Commitment Therapy (ACT), and more!

In this exclusive course, you sit side-by-side with Linda Curran as she interviews an all-star cast of renowned experts who will show you exactly how PAP has turned the field of trauma treatment upside down. AND, how to integrate PAP with Internal Family Systems (IFS), Polyvagal Theory, Acceptance and Commitment Therapy (ACT), and more!

Featuring rarely seen expert-to-expert clinical conversations with…

Bessel van der Kolk, MD, on differentiating ketamine, MDMA, and psilocybin.

Stephen Porges, PhD, on integrating psilocybin-assisted therapy with Polyvagal Theory.

Stacia Butterfield on altered state healing with breathwork.

Leslie Korn, PhD, MPH, LMHC, ACS, FNTP, BCTMB, on assessing which clients are right for PAP.

Rosalind Watts, PhD, on building trust and rapport to get the most out of PAP.

Victor Cabral, MSW, LSW, CCTP-I, on treating veterans with PTSD, chronic pain, insomnia, anxiety & more.

Hannah McLane, MD, MA, MPH, on psychedelic legalization and ethical facilitator education.

You walk away with a complete framework for how psychedelic medicine and other altered-state healing practices are evolving trauma treatment and how they can elevate your practice today!

Get started now!

Psychedelic-Assisted Psychotherapy for Complex Trauma:

Name: Psychedelic-Assisted Psychotherapy for Complex Trauma: Core Principals and Clinical Applications for the Future of Trauma Treatment
SKU: CRS001807
Price: 158.32 GBP
Availability: InStock

Core Principals and Clinical Applications for the Future of Trauma Treatment

Usually £298.99 — Yours Today for £158.32

Plus, earn 12 CPD Hours at no additional cost to you!
Click here for course objectives and outline

WHAT WILL I LEARN?

Get powerful new treatment strategies, anchored to modalities you're already using (like IFS, ACT, and Polyvagal Theory), in this easily accessible course designed for clinicians at any stage of their PAP journey.

Develop a deeper understanding of the various psychedelic medications available for trauma treatment — both pharmaceutical and plant-based varieties — including MDMA, psilocybin, ketamine, ayahuasca, psychedelic cannabis, and more.

Differentiate the ways each medication treats unique trauma wounds and recognize the appropriate time and setting for each.

Discover non-psychedelic forms of altered-state healing, including breath and sound work and guided imagery.

Learn how to support clients looking for PAP, even if you can't offer the services yourself.

Earn 12 CPD Hours at no additional cost to you!

Part 1: MDMA & MDMA Assisted Psychotherapy

Discover ways MDMA therapy can address ACES and treat childhood trauma, plus IFS Founder Richard Schwartz shows you how to integrate MDMA Therapy with Internal Family Systems.

You'll get an introduction to Holotropic Breathwork (a powerful form of altered-state healing that doesn't require medicine) and develop a deeper understanding of the role music can play in Psychedelic-Assisted Psychotherapy.

MDMA Therapy

Interview with Michael Mithoefer, MD
Interview with Victor Cabral, LSW, CCTP-I
Interview with Jim Hopper, PhD
Interview with Rosalind Watts, PhD
Interview with Hannah McLane, MD, MA, MPH

History & Pharmacology of MDMA

Holotropic Breathwork
- Interview with Michael Mithoefer, MD
- Interview with Stacia Butterfield
- Interview with Jim Hopper, PhD
- Interview with Bessel van der Kolk, MD

Drugscience.org.uk MDMA Information

What is MDMA
Scheduling of Drugs (www.dea.gov)
Drug Classes
- Stimulants
- Hallucinogens
- Dissociative Anesthetics
Risks of MDMA
MDMA Pharmacology
Psychoactive Properties
Physiological Effects
Psychological Effects
Therapeutic Applications
Treatment Process & Steps

MDMA Treatment Process/Steps

ACES & Childhood Trauma: Interview with Deran Young, LCSW
Trauma-Informed Care: Interview with Victor Cabral, LSW, CCTP-I
MDMA Outcomes: Interview with Michael Mithoefer, MD
Internal Family Systems Therapy: Interviews with Richard Schwartz, PhD; Bessel van der Kolk MD; Deran Young, LCSW
MDMA Therapy: Set & Setting: Interview with Jennifer Baldwin, PhD
Music in Psychedelic-Assisted Therapy: Interview with Mendel Kaelen, PhD
Significance of Trauma: Interview with Leslie Korn, PhD, MPH
Preparation, Medicine, Integration: Interview with Jennifer Baldwin, PhD & Jim Hopper PhD

Conclusion of Part 1

Resources

Part 2: Psilocybin & Psilocybin Assisted Therapy

Dive into the world of Psilocybin Assisted Therapy and discover how to apply it to common modalities and strategies you're already using, like Guided Imagery, Acceptance & Commitment Therapy, and the Polyvagal Theory (from theory founder Stephen Porges).

You'll learn more about psilocybin trials for depression treatment, why more research is needed, and how touch is used in clinical work — including discussions regarding therapist accountability and harm reduction.

How to Start Working with Medicines: Interview with Jennifer Baldwin, PhD
Education to do Medication Work, Good Trauma Treatment, & Psychedelic Treatment in Trauma Informed Therapy: Interview with Jim Hopper, PhD
Education with Medications: Michael Mithoefer, MD

Other Drugs: Interview with Jennifer Baldwin, PhD

Introduction to Ketamine
Psychedelic Cannabis
MDMA
Classic Psychedelics

Drugscience.org.uk Psilocybin Information

What is Psilocybin
Psilocybin History
Potential Harm
Psilocybin Pharmacology
Therapeutic Applications, Mechanisms, & Practicalities
Preparatory Psychotherapy
Active Psilocybin Sessions
Integrative Psychotherapy
Why We Need More Research

Interview with Rosalind Watts, PhD

Psilocybin Trails for Depression at the Imperial College in London, Visualization, Treatment Preparation, Integration, & Psychological Flexibility
Guided Imagery: Interview with Belleruth Naparstek
Challenges with Schedules for Treatment: Interview with Michael Mithoefer, MD
Acceptance & Commitment Therapy, Being Grounded in the Body, Trauma & Addiction: Interview with Jim Hopper, PhD

The Polyvagal Theory

Interview with Stephen Porges, PhD
Interview with Bessel van der Kolk, MD
Interview with Rosalind Watts, PhD

Underground Therapists & Clinical Implications

Interview with Michael Mithoefer, MD
Interview with Jim Hopper, PhD
Interview with Bessel van der Kolk, MD

Touch in Clinical Work

Harry Harlow Monkey Studies
Brain Development: Interview with Linda Curran
Permission to Touch: Interview with Michael Mitheofer, MD
Therapist Accountability: Interview with Jim Hopper, PhD
Accountability & Safety: Interview with Rosalind Watts, PhD
Medication Treatment Guidelines & Psychedelic Education: Interview with Bessel van der Kolk, MD
Medication Treatment Guidelines: Interview with Mendel Kaelen, PhD
Harm Reduction: Interview with Jennifer Baldwin, PhD

Conclusion of Part 2

Resources

Part 3: Ketamine & Ketamine Assisted Psychotherapy

Find out how to facilitate safe experiences, centred on inclusivity and equity, using Ketamine Assisted Psychotherapy, as well as create emotional and psychological safety for your marginalized clients.

You'll discover how ketamine therapy can be combined with IFS strategies to maximize treatment and get the latest information and valuable clinical insights regarding psychedelic legalization and regulation.

Experiences with Ketamine & Creating Safety: Interview with Bessel van der Kolk, MD

Facilitating Experiences: Interview with Mendel Kaelen, PhD

Interview with Jennifer Baldwin, PhD

MDMA Assisted Group Therapy
Set & Setting
What is the Wound? What is the Practice? What is the Medicine?
Circular Conscious Breathing

Interview with Staci Butterfield

Somatic Awareness
Plant Medicine & Holotropic Breathwork
Stan Grof: The Healing Potential of Non-Ordinary States of Consciousness Video Clips
Grof Cartography of the Psyche
Exploration of Breath
Breathwork
Music for Holotropic Breathwork: Interview with Mendel Kaelen, PhD
Contraindications to Holotropic Breathwork

Interview with Bessel van der Kolk, MD

Clinical Experiences Working with Patients Using Ketamine & MDMA
Positive & Negative Impacts of MDMA & Ketamine
How to Introduce Ketamine to Clients

Interview with Leslie Korn, PhD, MPH

Complex Trauma & the Importance of Creating Safety
Dissociative Drugs

Interview with Jim Hopper, PhD

Preparation for Ketamine Assisted Therapy
Clinical Experiences Using Ketamine

Drugscience.org.uk Ketamine Information

What is Ketamine?
Recreational Use & Mental Health Use
Ketamine Research
Ketamine Pharmacology
Ketamine Assisted Psychotherapy & Off-Label Ketamine Treatment

Ketamine in Clinical Context: Interview with Jennifer Baldwin, PhD

The Differential Effects of Psychedelic Drugs: Interview with Bessel van der Kolk, MD

Being a Medical Doctor Providing Ketamine: Interview with Michael Mitheofer, MD

Internal Family Systems & Ketamine: Interviews with Deran Young, LCSW & Jennifer Baldwin, PhD

Interview with Victor Cabral, LSW, CCTP-I

Policy in the Psychedelic State
Post Graduate Certificate in Ketamine Assisted Therapy
Personal Experiences with Ketamine
Internal Family Systems & Ketamine and Communal Healing

Hannah McLane, MD, MA, MPH

Ketamine Assisted Psychotherapy with Psychoanalysis
Psilocybin Facilitators Teachings
Psychedelic Legalization

Benefits, Intention, & Processing of Psychedelics: Interviews with Jim Hopper, PhD & Michael Mithoefer, MD

Interview with Hannah McLane, MD, MA, MPH

Inner Healing
Intelligence
Neuroplasticity

Holding the Space for Clients in a Psychedelic State: Interview with Jim Hopper, PhD

Psychedelic Teaching Programs & Resources: Interview with Michael Mithoefer, MD

Interview with Deran Young, LCSW

Internal Family Systems
Collective Resonance of Parts
Creating Emotional and Psychological Safety at Work for Marginalized People
Inclusivity & Equity

Interview with Victor Cabral, LSW, CCTP-I

Making Polices & Regulations for Psychedelics
Documentary: “Transcendence” Trailer

Conclusion of Part 3 & Psychedelic-Assisted Therapy Program

Resources & Teaching Recommendations
Contributor Bios

Psychedelic-Assisted Psychotherapy for Complex Trauma:
Core Principals and Clinical Applications for the Future of Trauma Treatment

Usually £298.99 — Yours Today for £158.32

Plus, earn 12 CPD Hours at no additional cost to you!
Click here for course objectives and outline

Course Experts

Linda A. Curran, BCPC, LPC, CAC-D, CCDPD, EMDR-C, sought after national trainer, best-selling author and film producer, has trained thousands of mental health clinicians across the country on trauma treatment. She is President of Integrative Trauma Treatment, LLC, in Havertown, PA. With advanced degrees in both clinical psychology and public health, Linda is a Board Certified, Licensed Professional Counselor; Certified Addiction Counselor Diplomate; Certified Co-Occurring Professional Diplomate; Certified Gestalt Therapist; Certified Neurofeedback Practitioner; Certified Hypnotherapist; and Level II EMDR Practitioner.

Click here for information about Linda Curran.

Michael Mithoefer, MD, is a psychiatrist living in Asheville, NC. He and his wife, Annie, completed the first MAPS-sponsored Phase II clinical trial testing MDMA-assisted psychotherapy for crime-related PTSD, a subsequent study with military veterans, firefighters, and police officers, and a pilot study treating couples with MDMA combined with Cognitive Behavioral Conjoint Therapy for PTSD.

Click here for information about Michael Mithoefer.

Victor Cabral, MSW, LSW, CCTP-I, (He/Him/His) is a collaborative and strategic leader who is making an impact on historical inequalities in his community and across the United States. Victor is the Founder of Dreamers of the Day, LLC, and serves as the Director of Policy and Regulatory Affairs for Fluence International Inc., a company that provides evidence-based training in psychedelic therapy and integration services to clinicians across the globe. Before joining Fluence, Victor served as Deputy Director for the Pennsylvania Governor's Office of Advocacy and Reform where he co-led the implementation of the Trauma-Informed PA Plan, helped establish the first Racial Day of Healing in state history, and developed free trauma trainings for Pennsylvanians in collaboration with BIPOC mental health and trauma, and psychedelic medicine.

Click here for information about Victor Cabral.

Jim Hopper, PhD, is a researcher and consultant most often sought for his expertise on the neurobiology of trauma and sexual assault, and on the unique experiences and needs of males who have experienced sexual abuse or sexual assault.

Since 2018, he has worked as a therapist and sub-investigator at the Boston site of the FDA-approved and MAPS-sponsored phase 3 trial of MDMA-Assisted Therapy for PTSD. He also provides ketamine-assisted psychotherapy in private practice and am a course director for a Harvard Medical School conference on psychedelic-assisted psychotherapy.

Click here for information about James W. Hopper.

Rosalind Watts, PhD, is a clinical psychologist, a mother, and a nature lover. Her work as the Clinical Lead for Imperial College London's psilocybin trial has made her one of the most prominent voices and minds in the field of psychedelic research.

Dr. Watts has been named as one of the 50 Most Influential People in Psychedelics as well as one of the Top 16 Women Shaping the Future of Psychedelics, with her focus on integration, harm-reduction, and inclusion in the psychedelic space.

Click here for information about Rosalind Watts.

Hannah McLane, MD, MA, MPH, is a physician, psychoanalyst, and entrepreneur. She is the Founder of SoundMind Institute, a Philadelphia and Oregon-based psychedelic facilitator training and research initiative aimed at bringing ethics, equity and innovation to the psychedelic ecosystem. She conducts research on cognitive diversity, psychedelic science, ethics, PTSD, and emerging alternative therapies for mental health issues.

Click here for information about Hannah McLane.

Stacia Butterfield is a certified Holotropic Breathwork facilitator. Over the last two decades she has introduced Holotropic Breathwork to large public groups and a variety of academic and professional settings, including California Institute of Integral Studies, Tel Aviv University, MAPS Psychedelic Science 2013 & 2017 conferences, Sophia University, Kripalu and the Fetzer Institute. Stacia's long interest in the wisdom of the body and deep trust in the intrinsic healing orientation of the psyche informs her work with others.

Click here for information about Stacia Butterfield.

Bessel A. van der Kolk, MD, is a clinician, researcher, and teacher in the area of post-traumatic stress. His work integrates developmental, neurobiological, psychodynamic, and interpersonal aspects of the impact of trauma and its treatment.

Dr. van der Kolk and his various collaborators have published extensively on the impact of trauma on development, such as dissociative problems, borderline personality and self-mutilation, cognitive development, memory, and the psychobiology of trauma. He has published over 150 peer-reviewed scientific articles on such diverse topics as neuroimaging, self-injury, memory, neurofeedback, Developmental Trauma, yoga, theatre, and EMDR.

Click here for information about Bessel A. van der Kolk.

Deran Young, LCSW, is a licensed therapist, CDWF, CDTL, Co-Author of New York Times Best Seller, You Are Your Best Thing, retired military officer, and the founder of Black Therapists Rock - a nonprofit organization committed to reducing the psychological impact of systemic oppression and intergenerational trauma.

Her passion for culture and people has led her to become a highly sought-after diversity and inclusion consultant working with companies like BBERG, Facebook, Linked In, Field Trip Health, and YWCA.

Click here for information about Deran Young.

Richard Schwartz, PhD, developed Internal Family Systems (IFS) in response to clients' descriptions of various parts within themselves. IFS is now evidence-based and has become a widely used form of psychotherapy, particularly with trauma. It provides a non-pathologizing, optimistic, and empowering perspective and a practical and effective set of techniques for working with individuals, couples, families, and more recently, corporations and classrooms.

Click here for information about Richard C. Schwartz.

Jennifer Baldwin, Rev., PhD, LPC, NCC, ACS, CIFST, SEP, KAP, BC-TMH, is a theologian, therapist, and trainer at Grounding Flight Wellness in Woodstock, GA, where she specializes in trauma recovery/PTSD, vocational discernment and school success, anxiety/depression, self-injury, and identity exploration. She also provides trainings for clergy and spiritual care professionals in trauma sensitive theology and religious leadership.

Click here for information about Jennifer Baldwin.

Mendel Kaelen, PhD, is the founder and CEO Of Wavepaths, an organization that enables therapists and clinicians to work with music in a truly person-centred way, as an extension of the therapeutic relationships with clients.

Prior to Wavepaths, he worked as a PhD and postdoctoral neuroscientist at Imperial College London since 2012, where his research was the one of the first to demonstrate music's central role in psychedelic therapies.

Click here for information about Mendel Kaelen.

Leslie Korn, PhD, MPH, LMHC, ACS, FNTP, BCTMB, is a renowned integrative medicine clinician and educator specializing in the use of nutritional, herbal and culinary medicine for the treatment of trauma and emotional and chronic physical illness. Her clinical practice focuses on providing clients effective alternatives to psychotropics.

She was a founder of the National Certification Board for Therapeutic Massage and Bodywork, a Fulbright scholar in Herbal Medicine and an NIH-funded scientist, in mind/body medicine. She is an approved clinical supervisor and is the research director at the Center for World Indigenous Studies where she designs culinary and herbal medicine programs with tribal communities engaged in developing integrative medicine programs.

Click here for information about Leslie Korn.

Belleruth Naparstek, ACSW, BCD, is a clinical social worker, author, and nationally recognized guided imagery pioneer, as well as the founder of Health Journeys — a multimedia company which specializes in self-help audio recordings of guided experiences, such as meditation, imagery, hypnosis, relaxation, acupressure and yoga.

She is widely recognized as a key force in making guided imagery — and its benefits — available in major, conventional health care institutions.

Click here for information about Belleruth Naparstek.

Stephen W. Porges, PhD, developer of the Polyvagal Theory, is a distinguished University Scientist at Indiana University, where he is the founding director of the Traumatic Stress Research Consortium within the Kinsey Institute. He holds the position of Professor of Psychiatry at the University of North Carolina and Professor Emeritus at the University of Illinois at Chicago and the University of Maryland and is a founder of the Polyvagal Institute. Dr. Porges served as president of both the Society for Psychophysiological Research and the Federation of Associations in Behavioral & Brain Sciences and is a former recipient of a National Institute of Mental Health Research Scientist Development Award.

Click here for information about Stephen Porges.

Psychedelic-Assisted Psychotherapy for Complex Trauma:
Core Principals and Clinical Applications for the Future of Trauma Treatment

Usually £298.99 — Yours Today for £158.32

Plus, earn 12 CPD Hours at no additional cost to you!
Click here for course objectives and outline

Frequently Asked Questions

Unlike other educational opportunities, this course paints the most complete picture of how psychedelic medicine and other altered-state healing practices (such as breathwork and music therapy) can evolve the trauma treatment process and elevate your practice.

Expert clinician Linda Curran hand selected a variety of premiere providers familiar with these medications and practices — including several modality-founding trauma experts, like Stephen Porges (the Polyvagal Theory) and Richard Schwartz (Internal Family Systems) — to discuss the ways they have revolutionized treatment.

Through a combination of research findings and captivating interviews, this program seeks to inform, explain, and evaluate the role of psychedelic medicine and Psychedelic-Assisted Psychotherapy for clinical practice and efficacy. You'll cover both pharmaceutical and plant-based medicines — including MDMA, psilocybin, ketamine, ayahuasca, psychedelic cannabis, and more.

Discover how these methods can provide longer lasting results, faster, without further traumatizing your clients and get answers to their questions about PAP, even if you can't offer the services yourself.

Just because the laws where you work don't allow you to administer psychedelic medicine, doesn't mean your clients won't have important questions about this increasingly popular practice. In fact, they could already be experimenting by micro-dosing outside of sessions with you.

This course will prepare you to expertly support them on their treatment journey by knowing the different types of psychedelic medications available — both pharmaceutical and plant-based varieties — as well as how each medication treats unique trauma wounds and recognizing the appropriate time and setting for each option.

You'll also get the somatic therapy techniques you need to help clients process their psychedelic experiences because PAP is not meant to replace psychotherapy, but rather enhance the healing results.

Plus, this course is packed full of non-psychedelic forms of altered-state healing, including breath and sound work, that are proven ways to treat trauma regardless of laws and location.

You'll have unlimited access to all course materials (video modules, online forums, and more!) as soon as you register, so there's no pressure to rush through the content.

This course was designed for (and by!) busy clinicians like you to be completed around your own schedule.

With nearly 12 hours of online video content, we encourage you to take the time to fully absorb everything. Watch the videos. Get your CE hours. You won't be disappointed with this highly effective Psychedelic-Assisted Psychotherapy (PAP) teaching your colleagues recommend!

But if you review all of the course materials and are still not satisfied, Contact Us . Your satisfaction is guaranteed.

Psychedelic-Assisted Psychotherapy for Complex Trauma:
Core Principals and Clinical Applications for the Future of Trauma Treatment

Usually £298.99 — Yours Today for £158.32

Plus, earn 12 CPD Hours at no additional cost to you!
Click here for course objectives and outline

100% Satisfaction Guarantee

Register for this intensive course without risk. If you're not completely satisfied, Contact Us.

We’re that confident you'll find this learning experience to be all that's promised and more than you expected.

NOTE: No additional discounts or coupons may be applied to this course.

Psychedelic-Assisted Psychotherapy for Complex Trauma: Core Principals and Clinical Applications for the Future of Trauma Treatment: Core Principals and Clinical Applications for the Future of Trauma Treatment

Psychedelic-Assisted Psychotherapy for Complex Trauma: